Literature DB >> 11799188

Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.

Thomas P Monath1, Juan Arroyo, Inessa Levenbook, Zhen-Xi Zhang, John Catalan, Ken Draper, Farshad Guirakhoo.   

Abstract

A chimeric yellow fever (YF) virus/Japanese encephalitis (JE) virus vaccine (ChimeriVax-JE) was constructed by insertion of the prM-E genes from the attenuated JE virus SA14-14-2 vaccine strain into a full-length cDNA clone of YF 17D virus. Passage in fetal rhesus lung (FRhL) cells led to the emergence of a small-plaque virus containing a single Met-->Lys amino acid mutation at E279, reverting this residue from the SA14-14-2 to the wild-type amino acid. A similar virus was also constructed by site-directed mutagenesis (J. Arroyo, F. Guirakhoo, S. Fenner, Z.-X. Zhang, T. P. Monath, and T. J. Chambers, J. Virol. 75:934-942, 2001). The E279 mutation is located in a beta-sheet in the hinge region of the E protein that is responsible for a pH-dependent conformational change during virus penetration from the endosome into the cytoplasm of the infected cell. In independent transfection-passage studies with FRhL or Vero cells, mutations appeared most frequently in hinge 4 (bounded by amino acids E266 to E284), reflecting genomic instability in this functionally important region. The E279 reversion caused a significant increase in neurovirulence as determined by the 50% lethal dose and survival distribution in suckling mice and by histopathology in rhesus monkeys. Based on sensitivity and comparability of results with those for monkeys, the suckling mouse is an appropriate host for safety testing of flavivirus vaccine candidates for neurotropism. After intracerebral inoculation, the E279 Lys virus was restricted with respect to extraneural replication in monkeys, as viremia and antibody levels (markers of viscerotropism) were significantly reduced compared to those for the E279 Met virus. These results are consistent with the observation that empirically derived vaccines developed by mouse brain passage of dengue and YF viruses have increased neurovirulence for mice but reduced viscerotropism for humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799188      PMCID: PMC135909          DOI: 10.1128/jvi.76.4.1932-1943.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.

Authors:  R J Hurrelbrink; P C McMinn
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination.

Authors:  I S Levenbook; L J Pelleu; B L Elisberg
Journal:  J Biol Stand       Date:  1987-10

3.  Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

Authors:  M Martin; T F Tsai; B Cropp; G J Chang; D A Holmes; J Tseng; W Shieh; S R Zaki; I Al-Sanouri; A F Cutrona; G Ray; L H Weld; M S Cetron
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

4.  Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.

Authors:  F Guirakhoo; J Arroyo; K V Pugachev; C Miller; Z X Zhang; R Weltzin; K Georgakopoulos; J Catalan; S Ocran; K Soike; M Ratterree; T P Monath
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Partial nucleotide sequence of the Japanese encephalitis virus genome.

Authors:  P C McAda; P W Mason; C S Schmaljohn; J M Dalrymple; T L Mason; M J Fournier
Journal:  Virology       Date:  1987-06       Impact factor: 3.616

Review 6.  West Nile virus vaccine.

Authors:  T P Monath; J Arroyo; C Miller; F Guirakhoo
Journal:  Curr Drug Targets Infect Disord       Date:  2001-05

7.  Variation in virulence for mice and rhesus monkeys among St. Louis encephalitis virus strains of different origin.

Authors:  T P Monath; C B Cropp; G S Bowen; G E Kemp; C J Mitchell; J J Gardner
Journal:  Am J Trop Med Hyg       Date:  1980-09       Impact factor: 2.345

8.  Complete nucleotide sequence of the Japanese encephalitis virus genome RNA.

Authors:  H Sumiyoshi; C Mori; I Fuke; K Morita; S Kuhara; J Kondou; Y Kikuchi; H Nagamatu; A Igarashi
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

9.  Sindbis virus: an efficient, broad host range vector for gene expression in animal cells.

Authors:  C Xiong; R Levis; P Shen; S Schlesinger; C M Rice; H V Huang
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

Review 10.  Yellow fever vector live-virus vaccines: West Nile virus vaccine development.

Authors:  J Arroyo; C A Miller; J Catalan; T P Monath
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

View more
  57 in total

1.  Molecular characterization of a hamster viscerotropic strain of yellow fever virus.

Authors:  Monica A McArthur; Miguel T Suderman; John-Paul Mutebi; Shu-Yuan Xiao; Alan D T Barrett
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Cloning and sequencing of complete cDNA of Japanese encephalitis virus YL strain in Taiwan.

Authors:  J J Liu; T H Tsai; T J Chang; M L Wong
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

3.  Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines.

Authors:  Raja Mazumder; Zhang-Zhi Hu; C R Vinayaka; Jose-Luis Sagripanti; Simon D W Frost; Sergei L Kosakovsky Pond; Cathy H Wu
Journal:  Virus Genes       Date:  2007-05-17       Impact factor: 2.332

4.  Neuropathogenesis and neurovirulence of live flaviviral vaccines in monkeys.

Authors:  Inessa Levenbook; Ken Draper
Journal:  J Virol       Date:  2009-05       Impact factor: 5.103

Review 5.  Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology.

Authors:  Bali Pulendran
Journal:  Nat Rev Immunol       Date:  2009-09-18       Impact factor: 53.106

6.  Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus.

Authors:  Haibin Liu; Yi Liu; Shaobo Wang; Yanjun Zhang; Xiangyang Zu; Zheng Zhou; Bo Zhang; Gengfu Xiao
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

7.  A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.

Authors:  F Guirakhoo; Z Zhang; G Myers; B W Johnson; K Pugachev; R Nichols; N Brown; I Levenbook; K Draper; S Cyrek; J Lang; C Fournier; B Barrere; S Delagrave; T P Monath
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.

Authors:  F Guirakhoo; K Pugachev; Z Zhang; G Myers; I Levenbook; K Draper; J Lang; S Ocran; F Mitchell; M Parsons; N Brown; S Brandler; C Fournier; B Barrere; F Rizvi; A Travassos; R Nichols; D Trent; T Monath
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  DNA-binding property of recombinant capsid protein of Japanese encephalitis virus.

Authors:  Hsi-Nuan Tseng; Chi-Chang Lee; Min-Liang Wong; Shu-O Chen; Jau-Jin Liu
Journal:  Virus Genes       Date:  2007-02-23       Impact factor: 2.332

10.  Expression of recombinant envelope protein of Japanese encephalitis virus YL strain in Escherichia coli possesses hemagglutination activity.

Authors:  S-O Chen; T-H Tsai; T-J Chang; M-L Wong; H-P Su; J-J Liu
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.